AU6519396A - Macrolides - Google Patents
MacrolidesInfo
- Publication number
- AU6519396A AU6519396A AU65193/96A AU6519396A AU6519396A AU 6519396 A AU6519396 A AU 6519396A AU 65193/96 A AU65193/96 A AU 65193/96A AU 6519396 A AU6519396 A AU 6519396A AU 6519396 A AU6519396 A AU 6519396A
- Authority
- AU
- Australia
- Prior art keywords
- macrolides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9513596.8A GB9513596D0 (en) | 1995-07-04 | 1995-07-04 | Organic compounds |
GB9513596 | 1995-07-04 | ||
GBGB9515495.1A GB9515495D0 (en) | 1995-07-28 | 1995-07-28 | Organic compounds |
GB9515495 | 1995-07-28 | ||
PCT/EP1996/002952 WO1997002285A1 (en) | 1995-07-04 | 1996-07-04 | Macrolides |
Publications (2)
Publication Number | Publication Date |
---|---|
AU6519396A true AU6519396A (en) | 1997-02-05 |
AU708004B2 AU708004B2 (en) | 1999-07-29 |
Family
ID=26307320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU65193/96A Ceased AU708004B2 (en) | 1995-07-04 | 1996-07-04 | Macrolides |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0836616A1 (en) |
JP (1) | JPH11509092A (en) |
KR (1) | KR19990028724A (en) |
CN (1) | CN1193979A (en) |
AR (1) | AR006514A1 (en) |
AU (1) | AU708004B2 (en) |
BR (1) | BR9609324A (en) |
CA (1) | CA2224715A1 (en) |
CO (1) | CO4750713A1 (en) |
CZ (1) | CZ424297A3 (en) |
HU (1) | HUP9802320A3 (en) |
IL (1) | IL122844A0 (en) |
NO (1) | NO980016L (en) |
PL (1) | PL324346A1 (en) |
SK (1) | SK498A3 (en) |
TR (1) | TR199800001T1 (en) |
WO (1) | WO1997002285A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124453A (en) * | 1995-07-04 | 2000-09-26 | Novartis Ag | Macrolides |
GB9811854D0 (en) * | 1998-06-02 | 1998-07-29 | Ciba Geigy Ag | Organic compounds |
US7368423B1 (en) * | 2001-12-05 | 2008-05-06 | The Scripps Research Institute | Composition and method for treating chronic allograft rejection |
CA2571710A1 (en) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
JP2008546708A (en) | 2005-06-17 | 2008-12-25 | ノバルティス アクチエンゲゼルシャフト | Use of sanglifehrin in HCV |
US8067024B2 (en) | 2006-02-10 | 2011-11-29 | Medtronic Vascular, Inc. | Medical devices to prevent or inhibit restenosis |
CN101289440B (en) * | 2007-06-29 | 2010-08-25 | 中国热带农业科学院热带生物技术研究所 | Polyene macrocyclic compounds, preparation thereof and applications |
ES2556211T3 (en) | 2008-09-24 | 2016-01-14 | Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences | Novel gene pooling |
WO2011098808A1 (en) | 2010-02-09 | 2011-08-18 | Biotica Technology Limited | Sanglifehrin based compounds |
ES2541853T3 (en) | 2010-02-09 | 2015-07-27 | Neurovive Pharmaceutical Ab | Sangliferin based compounds |
WO2011098805A1 (en) | 2010-02-09 | 2011-08-18 | Biotica Technology Limited | Sanglifehrin based compounds |
GB201008123D0 (en) | 2010-05-17 | 2010-06-30 | Biotica Tech Ltd | Novel compounds |
AR084217A1 (en) | 2010-12-10 | 2013-05-02 | Gilead Sciences Inc | MACROCICLIC INHIBITORS OF VIRUS FLAVIVIRIDAE |
CA2822347C (en) * | 2010-12-20 | 2019-11-05 | Neurovive Pharmaceutical Ab | Sanglifehrin derivatives and methods for their production |
JO3063B1 (en) | 2011-03-29 | 2017-03-15 | Neurovive Pharmaceutical Ab | Novel compound and methods for its production |
GB201118334D0 (en) | 2011-10-24 | 2011-12-07 | Biotica Tech Ltd | Novel dosage form |
PL2861604T3 (en) | 2012-06-08 | 2017-08-31 | Gilead Sciences, Inc. | Macrocyclic inhibitors of flaviviridae viruses |
AR091279A1 (en) | 2012-06-08 | 2015-01-21 | Gilead Sciences Inc | MACROCICLIC INHIBITORS OF VIRUS FLAVIVIRIDAE |
WO2013185090A1 (en) | 2012-06-08 | 2013-12-12 | Gilead Sciences, Inc. | Macrocyclic inhibitors of flaviviridae viruses |
JP2019535726A (en) | 2016-11-18 | 2019-12-12 | ネウロビベ プハルマセウトイカル エービー | Use of sanglifehrin macrocyclic analogues as anticancer compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9318144D0 (en) * | 1993-09-01 | 1993-10-20 | Sandoz Ltd | Organic compounds |
WO1995015328A1 (en) * | 1993-11-30 | 1995-06-08 | Abbott Laboratories | Macrocyclic immunomodulators with novel cyclohexyl ring replacements |
-
1996
- 1996-07-03 AR ARP960103427A patent/AR006514A1/en unknown
- 1996-07-04 PL PL96324346A patent/PL324346A1/en unknown
- 1996-07-04 TR TR1998/00001T patent/TR199800001T1/en unknown
- 1996-07-04 CZ CZ974242A patent/CZ424297A3/en unknown
- 1996-07-04 CA CA002224715A patent/CA2224715A1/en not_active Abandoned
- 1996-07-04 HU HU9802320A patent/HUP9802320A3/en unknown
- 1996-07-04 BR BR9609324A patent/BR9609324A/en not_active Application Discontinuation
- 1996-07-04 AU AU65193/96A patent/AU708004B2/en not_active Ceased
- 1996-07-04 SK SK4-98A patent/SK498A3/en unknown
- 1996-07-04 JP JP9504832A patent/JPH11509092A/en active Pending
- 1996-07-04 WO PCT/EP1996/002952 patent/WO1997002285A1/en not_active Application Discontinuation
- 1996-07-04 CN CN96196487A patent/CN1193979A/en active Pending
- 1996-07-04 CO CO96034982A patent/CO4750713A1/en unknown
- 1996-07-04 IL IL12284496A patent/IL122844A0/en unknown
- 1996-07-04 KR KR1019980700022A patent/KR19990028724A/en not_active Application Discontinuation
- 1996-07-04 EP EP96924886A patent/EP0836616A1/en not_active Withdrawn
-
1998
- 1998-01-02 NO NO980016A patent/NO980016L/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL324346A1 (en) | 1998-05-25 |
HUP9802320A3 (en) | 1999-03-29 |
CZ424297A3 (en) | 1998-04-15 |
AR006514A1 (en) | 1999-09-08 |
MX9800217A (en) | 1998-07-31 |
NO980016D0 (en) | 1998-01-02 |
IL122844A0 (en) | 1998-08-16 |
CA2224715A1 (en) | 1997-01-23 |
CO4750713A1 (en) | 1999-03-31 |
EP0836616A1 (en) | 1998-04-22 |
HUP9802320A2 (en) | 1999-02-01 |
KR19990028724A (en) | 1999-04-15 |
BR9609324A (en) | 1999-05-25 |
AU708004B2 (en) | 1999-07-29 |
JPH11509092A (en) | 1999-08-17 |
TR199800001T1 (en) | 1998-04-21 |
WO1997002285A1 (en) | 1997-01-23 |
CN1193979A (en) | 1998-09-23 |
NO980016L (en) | 1998-03-02 |
SK498A3 (en) | 1998-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5235796A (en) | o-hydroxyphenyl-s-triazines | |
AU4780896A (en) | Core-board | |
AU6000496A (en) | Phenylpyridazinones | |
AU4380797A (en) | Macrolides | |
AU5896396A (en) | Pyridine-microbicides | |
AU1030997A (en) | Taphane | |
AU6519396A (en) | Macrolides | |
AU4996696A (en) | 2-benzyl-3-arylbenzothiophenes | |
AU5147496A (en) | Fucopeptides | |
AU6235496A (en) | Azothiophenes | |
AU5593896A (en) | Benzisothiazolyl-substituted aminomethylchromans | |
AU5500196A (en) | Anti-transpirants | |
AU4382896A (en) | Acetylimidazobenzodiazepines | |
AU5108596A (en) | Morphine-3-esters | |
AU7038196A (en) | 1-azinyl-tetrazolinones | |
AU7415996A (en) | Antibiotic macrolides | |
AU6215196A (en) | Piperidinylmethyloxazolidinones | |
AU5917896A (en) | Poly-beta-1-4-N-acetylglucosamine | |
AU5013796A (en) | Wireclamp | |
AU5107096A (en) | Haemodialyser | |
AU6840796A (en) | Sack-holder | |
AU4569496A (en) | Tetralinyl- and indanyl-ethylamides | |
AU6658396A (en) | Polyhydroxyalkylamidobetaine | |
AU7694696A (en) | Cyclopeptolides | |
AU7565396A (en) | Fluorobutenoyloxyacetamides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |